(Q37162708)

18 August 2017

1 reference

title

Acute hepatitis C: a systematic review (English)

1 reference

18 August 2017

1 reference

1 reference

Sanaa M Kamal

1

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 May 2008

1 reference

The American Journal of Gastroenterology

18 August 2017

published in

1 reference

18 August 2017

volume

103

1 reference

18 August 2017

issue

5

1 reference

18 August 2017

page(s)

1283-97; quiz 1298

1 reference

Global burden of disease (GBD) for hepatitis C.

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Global epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Changing epidemiology of parenterally transmitted viral hepatitis: results from the hepatitis surveillance system in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C: a multifaceted disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C virus infection: a neglected disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C: diagnosis and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Epidemiology of hepatitis C: geographic differences and temporal trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Epidemiology of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Incident hepatitis C virus infection in a community-based population in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Persistent hyperendemicity of hepatitis C virus infection in Taiwan: the important role of iatrogenic risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Intrafamilial transmission of hepatitis C in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Changing patterns of acute viral hepatitis at a major urban referral center in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Active surveillance for acute viral hepatitis in rural villages in the Nile Delta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Children with hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Higher clearance of hepatitis C virus infection in females compared with males

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Epidemiology of hepatitis C in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Prevalence and screening costs of hepatitis C virus among Ugandan blood donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Hepatitis C virus infection and needle exchange use among young injection drug users in San Francisco

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Factors associated with injecting risk behaviour among serial community-wide samples of injecting drug users in Glasgow 1990-94: implications for control and prevention of blood-borne viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral load

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Clinical presentation and course of acute hepatitis C infection in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Estimation of the risk of transmission of hepatitis C between spouses in Egypt based on seroprevalence data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Cellular immune responses in seronegative sexual contacts of acute hepatitis C patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

National surveillance of dialysis-associated diseases in the United States, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C in patients receiving hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Risk factors for HCV infection in two haemodialysis units in The Netherlands

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Prospective virological follow-up of hepatitis C infection in a haemodialysis unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C among Japanese hemodialysis patients: a prospective 9-year study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Transmission of hepatitis C virus in Asia: past and present perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Prevalence of and risk factors for hepatitis C in rural pregnant Egyptian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Needlestick transmission of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Needlestick injuries in a tertiary care centre in Mumbai, India

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Occupational exposure to needlestick injuries and hepatitis B vaccination coverage among health care workers in Egypt

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Intrafamilial transmission of hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Prospective evaluation of community-acquired acute-phase hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Outcomes and Treatment of Acute Hepatitis C Virus Infection in a United States Population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4(+) T-cell and cytokine response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Hepatitis C in transplant recipients of solid organs, other than liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Analysis of successful immune responses in persons infected with hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Determinants of viral clearance and persistence during acute hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Cellular immune responses persist and humoral responses decrease two decades after recovery from a single-source outbreak of hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

High rate of spontaneous clearance of acute hepatitis C virus genotype 3 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Increased numbers of acute hepatitis C infections in HIV positive homosexual men; is sexual transmission feeding the increase?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Interferon for acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Treatment of acute hepatitis C with interferon alfa-2b

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Short-term interferon-alfa therapy for acute hepatitis C: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Treatment of acute hepatitis C with interferon alpha-2b: early initiation of treatment is the most effective predictive factor of sustained viral response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

American Gastroenterological Association technical review on the management of hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Efficacy of a 24-week course of PEG-interferon alpha-2b monotherapy in patients with acute hepatitis C after failure of spontaneous clearance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Pegylated interferon alpha therapy in acute hepatitis C: relation to hepatitis C virus-specific T cell response kinetics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Early monotherapy with pegylated interferon alpha-2b for acute hepatitis C infection: the HEP-NET acute-HCV-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Duration of peginterferon therapy in acute hepatitis C: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

A short course of pegylated interferon-alpha in acute HCV hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Twelve-week treatment of acute hepatitis C virus with pegylated interferon- alpha -2b in injection drug users

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Efficacy of early treatment of acute hepatitis C infection with pegylated interferon and ribavirin in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Transmission of hepatitis C virus among HIV-positive homosexual men and response to a 24-week course of pegylated interferon and ribavirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Treatment of acute hepatitis C infection in HIV-infected patients: a retrospective analysis of eleven cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1572-0241.2008.01825.X

10.1111/J.1572-0241.2008.01825.X

21 January 2018

Identifiers

DOI

1 reference

release_pduvopntpzdsnbbs3gyuatxhvi

18 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pduvopntpzdsnbbs3gyuatxhvi

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference